Intraocular shunt implantation
AssigneeAqueSys, Inc.
InventorsChristopher Horvath, Laszlo O. Romoda, Richard A. Lewis
Life of this patent
Estimating the term…
Abstract
Glaucoma can be treated by implanting an intraocular shunt in the eye. The implantation can be performed by first determining an entry area below a corneal limbus of an eye. Thereafter, the intraocular shunt can be inserted into eye tissue through the entry area such that an inflow end of the shunt is positioned in the anterior chamber of the eye and an outflow end of the shunt is positioned between layers of Tenon's capsule.
Claims20
A method of treating glaucoma comprising determining an entry area posterior to a corneal limbus of an eye and inserting an intraocular shunt into eye tissue through the entry area such that an inflow end of the shunt is positioned in the anterior chamber of the eye and an outflow end of the shunt is positioned between layers of Tenon's capsule.
A method of treating glaucoma comprising determining an entry area posterior to a corneal limbus of an eye and inserting an intraocular shunt into eye tissue through the entry area such that first end of the shunt is positioned in the anterior chamber of the eye and a second end of the shunt is positioned between layers of Tenon's capsule.
An ab externo intraocular shunt insertion technique wherein the shunt enters an eye via the sclera and is positioned so as to extend from the anterior chamber of the eye to a region between layers of Tenon's capsule.
Dependencies are inferred from the claim text.